Lista de obras - Aleksandra Toloczko-Grabarek

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases

scientific article published on 25 June 2019

A high proportion of founder BRCA1 mutations in Polish breast cancer families

artículo científico publicado en 2004

An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2008

Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor

artículo científico publicado en 2022

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

artículo científico publicado en 2015

BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms

artículo científico publicado en 2009

Breast cancer predisposing alleles in Poland

artículo científico publicado en 2005

CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland

artículo científico publicado en 2010

CHAPTER 22. Selenium and Cancer

artículo científico publicado en 2015

Colour Doppler ultrasound in preoperative assessment of the neck vessels in patients with tumours of the oral cavity and the neck region

artículo científico publicado en 2004

Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE)

scientific article published on 17 June 2020

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

artículo científico publicado en 2017

Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland

artículo científico publicado en 2022

Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in polish population

artículo científico publicado en 2022

Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene

artículo científico publicado en 2002

Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

artículo científico publicado en 2016

Iron and breast cancer risk

artículo científico publicado en 2012

Low-risk Genes and Multi-organ Cancer Risk in the Polish Population

artículo científico publicado en 2006

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

artículo científico publicado en 2013

MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.

artículo científico publicado en 2018

Nuclear Pedigree Criteria for the Identification of Individuals Suspected to be at Risk of an Inherited Predisposition to Renal Cancer

artículo científico publicado en 2005

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2012

Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory study

scientific article published on 11 May 2012

Population screening for cancer family syndromes in the west pomeranian region of poland

artículo científico publicado en 2006

Premature menopause in patients with BRCA1 gene mutation

artículo científico publicado en 2006

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer

artículo científico publicado en 2021

Selenium as a marker of cancer risk and of selection for control examinations in surveillance

artículo científico publicado en 2015

Selenium as marker for cancer risk and prevention

artículo científico publicado en 2012

Serum concentration of iron as predictor of cancer risk among BRCA1 mutation carriers.

artículo científico publicado en 2012

Serum concentration of selected macro- and microelements and their correlation with the risk of breast and ovarian cancer among BRCA1 mutation carriers

Smoking related cancers and loci at chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish population

artículo científico publicado en 2011

The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2010

Lista de obras de Aleksandra Toloczko-Grabarek

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases

A high proportion of founder BRCA1 mutations in Polish breast cancer families

An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers

Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms

Breast cancer predisposing alleles in Poland

CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland

CHAPTER 22. Selenium and Cancer

Colour Doppler ultrasound in preoperative assessment of the neck vessels in patients with tumours of the oral cavity and the neck region

Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE)

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland

Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in polish population

Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene

Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

Iron and breast cancer risk

Low-risk Genes and Multi-organ Cancer Risk in the Polish Population

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.

Nuclear Pedigree Criteria for the Identification of Individuals Suspected to be at Risk of an Inherited Predisposition to Renal Cancer

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory study

Population screening for cancer family syndromes in the west pomeranian region of poland

Premature menopause in patients with BRCA1 gene mutation

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer

Selenium as a marker of cancer risk and of selection for control examinations in surveillance

Selenium as marker for cancer risk and prevention

Serum concentration of iron as predictor of cancer risk among BRCA1 mutation carriers.

Serum concentration of selected macro- and microelements and their correlation with the risk of breast and ovarian cancer among BRCA1 mutation carriers

Smoking related cancers and loci at chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish population

The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers